Engineering and Development

Marketing

Management and Executive

Sales

Chief Financial Officer

Senior Director of Technology, Gene Therapy

Repligen reports Q3 adjusted EPS 46c, consensus 42c

Repligen sees FY25 adjusted EPS $1.65-$1.68, consensus $1.69

Repligen shares rise 3% as Q3 revenue growth tops expectations

Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance

Bioprocessing Account Manager

Repligen Corporation is a bioprocessing-focused life sciences company dedicated to advancing the production of biologic drugs. They are seeking a highly motivated Account Manager to drive sales and develop strategic relationships within the San Francisco Bay Area, focusing on upstream and downstream processing solutions.

Bioprocessing Account Manager- Remote -San Francisco Bay Area, CA

Director, Inside Sales

Global Strategic Bioproduction Account Manager

Bioprocess Account Manager

Global Strategic Bioproduction Account Executive

Sign up with Google

Sign in with Google